Jana Skrickova

Brno, JM 62500, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

N-glycans in lung tissue specimens: a prospective target for enhanced cancer diagnosis and prognosis.

N-glycans in lung tissue specimens: a prospective target for enhanced cancer diagnosis and prognosis.

Journal: Journal of translational medicine

Published: March 23, 2025

Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor.

Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor.

Journal: Digestive diseases (Basel, Switzerland)

Published: September 19, 2023

Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.

Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer.

Journal: Journal of cancer research and clinical oncology

Published: July 11, 2023

Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.

Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.

Journal: Cancer diagnosis & prognosis

Published: December 21, 2021

Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.

Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.

Journal: Anticancer research

Published: September 20, 2021

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.

Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.

Journal: Anticancer research

Published: August 30, 2021

Lung cancer - dia nosis and early detection.

Lung cancer - dia nosis and early detection.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: June 22, 2021

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.

Journal: Cancer treatment and research communications

Published: May 01, 2021

Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.

Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.

Journal: Anticancer research

Published: March 31, 2021

Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study.

Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study.

Journal: Anticancer research

Published: January 30, 2021

Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.

Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.

Journal: Thoracic cancer

Published: July 17, 2020

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.

Journal: Anticancer research

Published: February 06, 2020

Showing 1-12 of 50

Last Updated: 09/26/2026